It looks like SGA is quite generous when it comes to dishing out option grants to himself. Oh ya, I'm sure there is a compensation committee looking out for the general shareholders. He likes to talk about Medafor dilution. He should be looking in the mirror. Definitely two faces to SGA. Another good reason why as a Medafor shareholder I do not want to be acquired by CRY.